Atypical benign epilepsy of childhood with rolandic spikes: Features of a subset requiring more than one medication for seizure control

Journal of Child Neurology

Volumn 17, Issue 12, 2002, Pages 901-904

  Al Twaijri, Waleed A ^a   Shevell, Michael I ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE CONTROL; ELECTROENCEPHALOGRAPHY; FEMALE; FOCAL EPILEPSY; GENDER; GRAND MAL SEIZURE; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEUROLOGY; ONSET AGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ROLANDIC EPILEPSY; SEIZURE; STATISTICAL ANALYSIS; TIC;

ANTICONVULSANTS; CARBAMAZEPINE; ELECTROENCEPHALOGRAPHY; EPILEPSY, ROLANDIC; FEMALE; HUMAN; MALE; RETROSPECTIVE STUDIES; SEIZURES; SUPPORT, NON-U.S. GOV'T;

EID: 0036998010     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Panayiotopoulos CP: Benign childhood epilepsy with centro-temporal spikes or rolandic seizures, in Panayiotopoulos CP (ed): Benign Childhood Partial Seizures and Related Epilepsies. New York, John Libbey & Company Ltd, 1999, 33-70.
2. Wirrell EC: Benign epilepsy of childhood with centrotemporal spikes. Epilepsia 1998;39(Suppl):S32-S41.
3. Yung AWY, Park YD, Cohen MJ, Garrison TN: Cognitive and behavioral problems in children with centrotemporal spikes. Pediatr Neurol 2000;23:391-395.
4. Shevell MI, Rosenblatt B, Watters GV, et al: "Pseudo-BECRS": Intracranial focal lesions suggestive of a primary partial epilepsy syndrome. Pediatr Neurol 1996;14:31-35.
5. Otsubo H, Chitoku S, Ochi A, et al: Malignant rolandic-sylvian epilepsy in children: Diagnosis, treatment, and outcomes. Neurology 2001;57:590-596.
6. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
7. Verrotti A, Latini G, Trotta D, et al: Typical and atypical rolandic epilepsy in childhood: A follow-up study. Pediatr Neurol 2002;26:26-29.
8. Wirrell EC, Camfield PR, Gordon KE, et al: Benign rolandic epilepsy: Atypical features are very common. J Child Neurol 1995;10:455-458.
9. Fejerman N, Di Blasi AM: Status epilepticus of benign partial epilepsies in children: Report of two cases. Epilepsia 1987;28:351-355.
10. Ong HT, Wyllie E: Benign childhood epilepsy with centrotemporal spikes: Is it always benign? Neurology 2000;54:1182-1185.
11. Fejerman N, Caraballo R, Tenembaum SN: Atypical evolutions of benign localization-related epilepsies in children: Are they predictable? Epilepsia 2000;41:380-390.
12. Weglage J, Demsky A, Pietsch M, Kurlemann G: Neuropsychological, intellectual and behavioral findings in patients with centro-temporal spikes with and without seizures. Dev Med Child Neurol 1997;39:646-651.
13. Baglietto M, Battaglia FM, Nobili L, et al: Neuropsychological disorders related to interictal epileptic discharges during sleep in benign epilepsy of childhood with centrotemporal or rolandic spikes. Dev Med Child Neurol 2001;43:407-412.
14. Staden U, Isaacs E, Boyd SG, et al: Language dysfunction in children with rolandic epilepsy. Neuropediatrics 1998;29:242-248.
15. Bouma PAD, Bovenkerk AC, Westendorp RGJ, Brouwer OF: The course of benign partial epilepsy of childhood with centrotemporal spikes: A meta-analysis. Neurology 1997;48:430-437.
16. Ambrosetto G, Tassinari CA: Antiepileptic drug treatment of benign childhood epilepsy with rolandic spikes: Is it necessary? Epilepsia 1990;31:802-805.
17. Kramer U, Zelnik N, Lerman-Sagie T, Shahar E: Benign childhood epilepsy with centrotemporal spikes: Clinical characteristics and identification of patients at risk for multiple seizures. J Child Neurol 2002;17:17-19.
18. McCabe PH: New anti-epileptic drugs for the 21st century. Exp Opin Pharmacol 2000;1:633-674.
19. Bawder HN, Camfield CS, Camfield PR, et al: The cognitive and behavioral efforts of clobazam and standard monotherapy are comparable. Epilepsy Res 1999;33:133-143.
20. Canadian Study Group for Epilepsy: Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Epilepsia 1998;39:952-959.
21. Seidel WT, Mitchell WG: Cognitive and behavioral effects of carbamazpeine in children: Data from benign rolandic epilepsy. J Child Neurol 1999;14:716-723.
22. Corda D, Gelisse P, Genton P, et al: Incidence of drug-induced aggravation in benign epilepsy with centrotemporal spikes. Epilepsia 2001;42:754-759.
23. Eeg-Olofsson O, Lundberg S, Raininko R: MRI in rolandic epilepsy. Epilept Disord 2000;2(Suppl 1):S51-S53.
24. Lundberg S, Eeg-Olofsson O, Raininko R, Eeg-Olofsson KE: Hippocampal asymmetries and white matter abnormalities on MRI in benign childhood epilepsy with centrotemporal spikes. Epilepsia 1999;40:1808-1815.
25. Neubauer BA, Fiedler B, Himmelein B, et al: Centrotemporal spikes in families with rolandic epilepsy: Linkage to chromosome 15q14. Neurology 1998;51:1608-1612.
26. Lewis TB, Shevell MI, Andermann E, et al: Evidence of a third locus for benign familial neonatal convulsions. J Child Neurol 1996;11:211-214.
27. Leppert MR, Singh N. Susceptibility genes in human epilepsy. Semin Neurol 1999;19:397-405.